Table 2 Comparison of clinical comorbidities between the groups
Variable | HSCT with AP | HSCT without AP | p |
|---|---|---|---|
Number of patients | 359 | 33,080 | |
Solid organ transplant | 107 (29.8) | 3530 (10.7) | <0.001 |
Primary immunodeficiency disorders | 85 (23.7) | 7664 (23.2) | 0.820 |
Graft versus host disease | 52 (14.5) | 2343 (7.1) | <0.001 |
Other biliary disease | 52 (14.5) | 1168 (3.5) | <0.001 |
Lymphoid leukemia | 39 (10.9) | 2499 (7.6) | 0.019 |
Choledocholithiasis | 28 (7.8) | 261 (0.8) | <0.001 |
Hemophagocytic lymphohistiocytosis | 27 (7.5) | 844 (2.6) | <0.001 |
Cholangitis | 23 (6.4) | 196 (0.6) | <0.001 |
Myeloid leukemia | 21 (5.8) | 1976 (6) | 0.922 |
Hypertriglyceridemia | 20 (5.6) | 583 (1.8) | <0.001 |
Myelodysplastic syndrome | 18 (5) | 737 (2.2) | <0.001 |
Alcohol | 16 (4.5) | 346 (1) | 0.000 |
Other solid tumors | 16 (4.5) | 4872 (14.7) | <0.001 |
Sickle cell disease | 11 (3.1) | 1012 (3.1) | 0.996 |
Inborn errors of metabolism | 8 (2.2) | 1176 (3.6) | 0.176 |
Hypercalcemia | 8 (2.2) | 239 (0.7) | 0.001 |
Inflammatory bowel disease | 8 (2.2) | 168 (0.5) | <0.001 |
Thalassemia | 3 (0.8) | 316 (1) | 0.817 |
Hemolytic uremic syndrome | 2 (0.6) | 42 (0.1) | 0.025 |
Abdominal trauma | 2 (0.6) | 46 (0.1) | 0.037 |
Non-Hodgkin’s lymphoma | 1 (0.3) | 220 (0.7) | 0.369 |
Diabetic ketoacidosis | 1 (0.3) | 7 (0) | 0.002 |
Cystic fibrosis | 1 (0.3) | 15 (0) | 0.044 |
Hodgkin’s lymphoma | 0(0) | 341 (1) | 0.053 |
Aplastic anemias and bone marrow failure syndromes | 0(0) | 8 (0) | 0.768 |
Systemic lupus erythematosus | 0(0) | 28 (0.1) | 0.581 |
Anomalies of pancreas | 0(0) | 5 (0) | 0.816 |
